Count Me In
@count_me_in
We engage all cancer patients in the United States and Canada to accelerate cancer research by sharing their medical information, samples, and experiences.
Watch here to learn more about how we enable cancer patients living in the United States and Canada to partner with researchers so, together, we can change the future of understanding disease. Visit JoinCountMeIn.org today to get started.
Wise words from Count Me In's dedicated Director of Operations, Diane, who brings her curiosity and drive to our operations every day - helping grow and scale our patient-partnered research efforts. See more on her journey: 🔗 broad.io/WISDiane
"Don't get too comfortable being comfortable." Diane Diehl’s advice for a thriving career in science: stay curious, keep learning, and talk about your goals. Her journey shows how scientists can thrive beyond the lab. 🔗:broad.io/WISDiane #WhyIScience #STEMCareers
Our latest paper in Genetics in Medicine from @PECGSnetwork shows how we define, measure, and optimize engagement with patient and community partners. Discover the strategies and early impacts of these approaches on our cancer genomics research. Read more: sciencedirect.com/science/articl…
Thanks @BuzzFeed and people-of-Reddit for your support of science, and for the cameo. Check out photo 6! buzzfeed.com/victoriavoulou…
BCL is proud to power the Catalyst program from @SoResearchNews with @MyOme - bringing free, clinical-grade genetic screening to adults across #Alabama. 🧬 High-throughput, CLIA-certified sequencing + results participants can trust. 🔗 Read more: abc3340.com/news/abc-3340-……
Missed the live session? Watch the webinar recording at the link in our bio, introducing the tRCC Project- a patient-partnered research initiative focused on translocation renal cell carcinoma. #tRCC #PatientPartneredResearch #KidneyCancer
What is tRCC? In our latest video, experts break down this rare subtype of #KidneyCancer, which affects younger patients and requires a different approach to diagnosis and treatment. Watch now + explore the Rare Subtypes playlist: bit.ly/RareSubtypes #AcceleratingCures
Integrating reporting for germline and tumor sequencing is key to equitable cancer care. @NatureMedicine Commentary by members of @PECGSnetwork advocates for integrated genetic reporting frameworks for a comprehensive genetic assessment. Read more: rdcu.be/enVCt
This #NationalCancerResearchMonth, we’re celebrating patient participation advancing research in rare cancers like tRCC, osteosarcoma, leiomyosarcoma, and PediHCC. Together, we’re building datasets that can drive discoveries. Learn more: joincountmein.org/scientific-res…
Today on World DNA Day, we celebrate the power of genomic data to drive discovery. Thank you to everyone in the Count Me In community who shares their data to help move cancer research forward. #WorldDNADay #CountMeIn
It’s #AYAware Week! 89,500 AYAs (15-39) are diagnosed with cancer each year in the U.S., yet they face higher drug costs, barriers to care, and are underrepresented in research. Join us in raising awareness & advocating for AYA cancer communities.
More impact, together! Count Me In is proud to join Broad Clinical Labs to expand access to research and center patients in biomedical discovery. Read more at the link below.
Count Me In (@count_me_in) & Broad Clinical Labs are teaming up to advance rare disease & cancer research! By combining patient engagement with high-throughput sequencing & genomic data analysis, we’re driving discovery forward. Learn more: bit.ly/42lnZPz #Genomics
We hope you'll join us next week to learn more about our tRCC patient-partnered research project! Register at tRCCProject.org.
Join us for a 1-hour session on Count Me In’s newest patient-partnered research initiative: the tRCC Project! Learn about its impact, patient collaboration, and next steps. Register now: trccproject.org #tRCC
As #KidneyCancerAwarenessMonth ends, the need for research continues. We launched the tRCC Project to drive progress for this rare kidney cancer because every patient's unique experience matters. Join us in making a lasting impact: trccproject.org.
CMI launched a research initiative for patients with translocation renal cell carcinoma (#tRCC). Physicians treating individuals with tRCC can help by sharing this opportunity with patients. Learn more at trccproject.org and request materials here: bit.ly/tRCCRequest
@count_me_in tRCC Project is now enrolling patients with translocation renal cell carcinoma to help advance research and treatment. If you have patients who may be eligible, pls refer them to this initiative. visit trccproject.org.
Join us for a 1-hour session on Count Me In’s newest patient-partnered research initiative: the tRCC Project! Learn about its impact, patient collaboration, and next steps. Register now: trccproject.org #tRCC
We're honored to launch our latest project on translocation renal cell carcinoma (tRCC) - a rare, aggressive kidney cancer. With few treatment options, the tRCC Project partners with patients, caregivers & advocates to drive research forward. Learn more: hubs.ly/Q03bhbST0
Did you know? Colorectal cancer is on the rise in younger adults, with cases in people under 50 increasing. Researchers are working to understand why - and patient-driven research can help. 🔬 Learn more and get involved: hubs.ly/Q038dpln0.
Count Me In is dedicated to patient-driven colorectal cancer research that has the power to accelerate discoveries. If you have ever been diagnosed with CRC, you can join us in making a difference. Learn more this #ColorectalCancerAwarenessMonth at hubs.ly/Q038ZTZf0.
Behind every breakthrough is a dedicated team. Meet a few of our staff working to accelerate cancer discoveries! #CountMeIn #CancerResearch
